Literature DB >> 7411303

Cerebro-costo-mandibular syndrome.

F N Silverman, A M Strefling, D K Stevenson, J Lazarus.   

Abstract

The cerebro-costo-mandibular syndrome is characterized by cerebral maldevelopment or malfunction or both, costal deficiencies, and micrognathia. Cleft palate and glossoptosis are frequently present and contribute to the common presenting sign, neonatal respiratory distress. Intrauterine and postnatal growth retardation are common. Familial cases are rare and the mode of transmission is uncertain. The deficiencies in the posterior portion of affected ribs are the sine qua non for diagnosis; roentgenographic confirmation is required. Since the first description of this pattern of prenatal growth defect in 1966, 19 patients who fulfill the criteria for diagnosis have been reported. We present three additional cases, one of which includes roentgenographic-pathologic correlations, and summarize the combinations of features present in previously described cases. Pulmonary complications incident to lack of thoracic cage support result in poor prognosis for survival.

Entities:  

Mesh:

Year:  1980        PMID: 7411303     DOI: 10.1016/s0022-3476(80)80190-9

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  4 in total

1.  Cerebro-costo-mandibular syndrome with consanguinity.

Authors:  E A Clarke; V D Nguyen
Journal:  Pediatr Radiol       Date:  1985

2.  Cerebrocostomandibular syndrome in four sibs, two pairs of twins.

Authors:  V Drossou-Agakidou; A Andreou; V Soubassi-Griva; M Pandouraki
Journal:  J Med Genet       Date:  1991-10       Impact factor: 6.318

3.  Cerebro-costo-mandibular syndrome with stippled epiphysis and cystic fibrosis.

Authors:  E M Burton; A E Oestreich
Journal:  Pediatr Radiol       Date:  1988

4.  Local modulation of the Wnt/β-catenin and bone morphogenic protein (BMP) pathways recapitulates rib defects analogous to cerebro-costo-mandibular syndrome.

Authors:  Benedict R H Turner; Nobue Itasaki
Journal:  J Anat       Date:  2019-12-29       Impact factor: 2.610

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.